Sphinx: a new cause of hepatic neoplasia

Sphinx:肝肿瘤的新病因

基本信息

  • 批准号:
    7637460
  • 负责人:
  • 金额:
    $ 16.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Hepatocellular carcinoma (HCC) accounts for 85% of primary malignant tumors of the liver and is the third most-common cause of cancer-related death in the world. Although its etiology is diverse, the development of HCC follows a common pathogenic profile with repetitive hepatic injury leading to cirrhosis, formation of hyperplastic nodules and accumulation of genetic aberrations. Using a forward genetic approach, we have identified an N-ethyl-N-nitrosourea (ENU)-induced germline mutant phenotype, called Sphinx that develops spontaneous multicentric liver tumors. Tumor formation is apparent by 5 weeks of age and histological analyses revealed that the tissue is well differentiated and no etastases were observed. In addition to hepatocellular tumor development, homozygous Sphinx mice exhibit abnormal lymphocyte development and lack peripheral CD8+ T and NK cells. The phenotypes behave as recessive traits and C57BL/6JSphinx/Sphinx mice die by 12 weeks of age. Coarse mapping placed the mutation in a small interval on chromosome 6, in which no obvious candidate genes were found. The goal of this proposal is to identify the gene carrying the mutation responsible for the described phenotypes. In addition, we intend to characterize the Sphinx phenotype in more detail and to study the interaction between the immune system and tumor cell development. We believe our studies will reveal a novel gene involved in HCC development and provide a new, useful, model system in which to study the interaction between the immune system and hepatocellular tumor formation. PUBLIC HEALTH RELEVANCE: The studies are aimed to identify a yet unknown tumor suppressor gene involved in hepatocellular adenoma/carcinoma development. In addition, using a unique mouse model identified in our laboratory, we aim to study the involvement of the immune system in the pathophysiology of hepatocellular tumor development.
描述(由申请人提供):肝细胞癌(HCC)占肝脏原发性恶性肿瘤的85%,是世界上第三大常见的癌症相关死亡原因。尽管其病因多种多样,但HCC的发展遵循一个共同的致病特征,即重复性肝损伤导致肝硬化、增生性结节的形成和遗传畸变的积累。使用正向遗传方法,我们已经确定了n -乙基-n -亚硝基脲(ENU)诱导的种系突变表型,称为Sphinx,可发展自发的多中心肝肿瘤。5周龄时肿瘤形成明显,组织学分析显示组织分化良好,未观察到转移。除了肝细胞肿瘤发展外,纯合子Sphinx小鼠还表现出淋巴细胞发育异常,缺乏外周CD8+ T和NK细胞。表型表现为隐性性状,C57BL/6JSphinx/Sphinx小鼠在12周龄时死亡。粗略的定位将突变定位在6号染色体上的一个小间隔内,没有发现明显的候选基因。这一建议的目标是确定基因携带的突变负责所描述的表型。此外,我们打算更详细地表征Sphinx表型,并研究免疫系统与肿瘤细胞发育之间的相互作用。我们相信我们的研究将揭示一个参与HCC发展的新基因,并为研究免疫系统与肝细胞肿瘤形成之间的相互作用提供一个新的、有用的模型系统。公共卫生相关性:这些研究旨在确定一种未知的参与肝细胞腺瘤/癌发展的肿瘤抑制基因。此外,利用我们实验室鉴定的一种独特的小鼠模型,我们旨在研究免疫系统在肝细胞肿瘤发展的病理生理中的参与。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KASPER HOEBE其他文献

KASPER HOEBE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KASPER HOEBE', 18)}}的其他基金

Functional analysis of NK cells and their potential to generate CTL responses
NK 细胞的功能分析及其产生 CTL 反应的潜力
  • 批准号:
    8091360
  • 财政年份:
    2009
  • 资助金额:
    $ 16.31万
  • 项目类别:
Functional analysis of NK cells and their potential to generate CTL responses
NK 细胞的功能分析及其产生 CTL 反应的潜力
  • 批准号:
    8289399
  • 财政年份:
    2009
  • 资助金额:
    $ 16.31万
  • 项目类别:
Functional analysis of NK cells and their potential to generate CTL responses
NK 细胞的功能分析及其产生 CTL 反应的潜力
  • 批准号:
    7580608
  • 财政年份:
    2009
  • 资助金额:
    $ 16.31万
  • 项目类别:
Immunobiology of IFRD1, a gene modifying CF lung disease
IFRD1(一种改变 CF 肺病的基因)的免疫生物学
  • 批准号:
    8131866
  • 财政年份:
    2009
  • 资助金额:
    $ 16.31万
  • 项目类别:
Immunobiology of IFRD1, a gene modifying CF lung disease
IFRD1(一种改变 CF 肺病的基因)的免疫生物学
  • 批准号:
    8316178
  • 财政年份:
    2009
  • 资助金额:
    $ 16.31万
  • 项目类别:
Functional analysis of NK cells and their potential to generate CTL responses
NK 细胞的功能分析及其产生 CTL 反应的潜力
  • 批准号:
    7885451
  • 财政年份:
    2009
  • 资助金额:
    $ 16.31万
  • 项目类别:
Sphinx: a new cause of hepatic neoplasia
Sphinx:肝肿瘤的新病因
  • 批准号:
    7449784
  • 财政年份:
    2008
  • 资助金额:
    $ 16.31万
  • 项目类别:
Regulation of TLR Signaling and Innate Immunity by RP105
RP105 对 TLR 信号传导和先天免疫的调节
  • 批准号:
    8085877
  • 财政年份:
    2007
  • 资助金额:
    $ 16.31万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.31万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了